SSE plc has announced interim results for the six months to 30 September 2025, with performance in line with expectations and adjusted earnings per share of 36.1p...
Nuformix has received an FDA request for clarification on its Orphan Drug Designation application for tranilast under the NXP002 programme. The company also reported its Open Offer was oversubscribed by 408%, raising around £228,000 before expenses...
Acuity has appointed Duncan Harper FCA as Finance Director with immediate effect. He replaces Kate Buchan, who is leaving to pursue other opportunities...
SSE plc has announced interim results for the six months to 30 September 2025, with performance in line with expectations and adjusted earnings per share of 36.1p...
Nuformix has received an FDA request for clarification on its Orphan Drug Designation application for tranilast under the NXP002 programme. The company also reported its Open Offer was oversubscribed by 408%, raising around £228,000 before expenses...
Acuity has appointed Duncan Harper FCA as Finance Director with immediate effect. He replaces Kate Buchan, who is leaving to pursue other opportunities...
